financetom
Business
financetom
/
Business
/
Dayforce Q2 Adjusted Earnings, Revenue Rise; 2024 Revenue Guidance Higher
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dayforce Q2 Adjusted Earnings, Revenue Rise; 2024 Revenue Guidance Higher
Jul 31, 2024 6:57 AM

09:01 AM EDT, 07/31/2024 (MT Newswires) -- Dayforce ( DAY ) reported Q2 adjusted earnings Wednesday of $0.48 per diluted share, up from $0.32 a year earlier.

Analysts polled by Capital IQ expected $0.36.

Revenue for the quarter ended June 30 was $423.3 million, up from $365.9 million a year earlier.

Analysts polled by Capital IQ expected $417 million.

The company expects Q3 revenue of $425 million to $430 million, versus analyst expectations for $430.4 million.

It expects 2024 revenue to be from $1.74 billion to $1.75 billion, higher than the previous guidance of $1.73 billion to $1.74 billion. Analysts polled by Capital IQ are expecting $1.74 billion.

Shares of the company were up 8% in recent Wednesday premarket activity.

Price: 57.98, Change: +4.30, Percent Change: +8.01

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--SpartanNash Keeps Quarterly Cash Dividend at $0.2175 a Share, Payable on June 28 to Shareholders as of June 14
--SpartanNash Keeps Quarterly Cash Dividend at $0.2175 a Share, Payable on June 28 to Shareholders as of June 14
May 23, 2024
10:38 AM EDT, 05/23/2024 (MT Newswires) -- Price: 20.66, Change: -0.07, Percent Change: -0.36 ...
Tango Therapeutics Stops Development of USP1 Inhibitor After Liver Toxicity Issues
Tango Therapeutics Stops Development of USP1 Inhibitor After Liver Toxicity Issues
May 23, 2024
11:02 AM EDT, 05/23/2024 (MT Newswires) -- Tango Therapeutics ( TNGX ) said Thursday it has decided to discontinue the development of USP1, or ubiquitin-specific protease 1, inhibitor TNG348 due to liver toxicity observed in patients during a phase 1/2 clinical trial. Liver function abnormalities were observed in patients who remained in the trial for longer than eight weeks, the...
Boeing CFO says second-quarter deliveries won't increase from the first quarter
Boeing CFO says second-quarter deliveries won't increase from the first quarter
May 23, 2024
May 23 (Reuters) - Boeing CFO Brian West said Thursday that commercial jet deliveries won't step up in the second quarter compared with the first three months of the year as the company reckons with production quality issues. West also told the Wolfe Research Global Transportation and Industrials Conference the planemaker's jet deliveries to China were delayed in recent weeks...
RTX's Collins Aerospace Wins Subcontract For US Air Force's SAOC Program
RTX's Collins Aerospace Wins Subcontract For US Air Force's SAOC Program
May 23, 2024
11:02 AM EDT, 05/23/2024 (MT Newswires) -- RTX (RTX) said Thursday its Collins Aerospace unit was awarded a multi-billion-dollar subcontract as part of a team led by Sierra Nevada Corp. to design, develop and deliver systems and products for a new aircraft under the US Air Force's Survivable Airborne Operations Center program. Financial details weren't disclosed. The SAOC program is...
Copyright 2023-2026 - www.financetom.com All Rights Reserved